![PDF] The conversion to metered-dose inhaler with valved holding chamber to administer inhaled albuterol: a pediatric hospital experience. | Semantic Scholar PDF] The conversion to metered-dose inhaler with valved holding chamber to administer inhaled albuterol: a pediatric hospital experience. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c68aa2399ed2c2fdcb1c686e8756eb6af886514e/5-Table2-1.png)
PDF] The conversion to metered-dose inhaler with valved holding chamber to administer inhaled albuterol: a pediatric hospital experience. | Semantic Scholar
![Albuterol Sulfate Inhalation Solution0.042% (1.25 mg*/3 mL) and 0.021% (0.63 mg*/3 mL)(*Potency expressed as albuterol, equivalent to 1.5 mgand 0.75 mg albuterol sulfate) Revised: January 2017 Rx only Albuterol Sulfate Inhalation Solution0.042% (1.25 mg*/3 mL) and 0.021% (0.63 mg*/3 mL)(*Potency expressed as albuterol, equivalent to 1.5 mgand 0.75 mg albuterol sulfate) Revised: January 2017 Rx only](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-8.jpg&id=427002)
Albuterol Sulfate Inhalation Solution0.042% (1.25 mg*/3 mL) and 0.021% (0.63 mg*/3 mL)(*Potency expressed as albuterol, equivalent to 1.5 mgand 0.75 mg albuterol sulfate) Revised: January 2017 Rx only
![Albuterol via metered‐dose inhaler in children: Lower doses are effective, and higher doses are safe - Muchão - 2016 - Pediatric Pulmonology - Wiley Online Library Albuterol via metered‐dose inhaler in children: Lower doses are effective, and higher doses are safe - Muchão - 2016 - Pediatric Pulmonology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/3da3e003-07d0-47ee-8c77-8739fb21eaad/ppul23469-fig-0001-m.jpg)
Albuterol via metered‐dose inhaler in children: Lower doses are effective, and higher doses are safe - Muchão - 2016 - Pediatric Pulmonology - Wiley Online Library
![Replacing nebulizers by MDI-spacers for bronchodilator and inhaled corticosteroid administration: Impact on the utilization of hospital resources | Semantic Scholar Replacing nebulizers by MDI-spacers for bronchodilator and inhaled corticosteroid administration: Impact on the utilization of hospital resources | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3101bfd9623e6639c72fe39afc806a9d4c9b4164/4-Table1-1.png)
Replacing nebulizers by MDI-spacers for bronchodilator and inhaled corticosteroid administration: Impact on the utilization of hospital resources | Semantic Scholar
![Albuterol Sulfate Inhalation Solution0.042% (1.25 mg*/3 mL) and 0.021% (0.63 mg*/3 mL)(*Potency expressed as albuterol, equivalent to 1.5 mgand 0.75 mg albuterol sulfate) Revised: January 2017 Rx only Albuterol Sulfate Inhalation Solution0.042% (1.25 mg*/3 mL) and 0.021% (0.63 mg*/3 mL)(*Potency expressed as albuterol, equivalent to 1.5 mgand 0.75 mg albuterol sulfate) Revised: January 2017 Rx only](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-7.jpg&id=427002)
Albuterol Sulfate Inhalation Solution0.042% (1.25 mg*/3 mL) and 0.021% (0.63 mg*/3 mL)(*Potency expressed as albuterol, equivalent to 1.5 mgand 0.75 mg albuterol sulfate) Revised: January 2017 Rx only
![Table 5 from Continuous nebulization therapy for asthma with aerosols of beta2 agonists. | Semantic Scholar Table 5 from Continuous nebulization therapy for asthma with aerosols of beta2 agonists. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/01a92c5ac112f986887d4d53e88aa803f480ad8c/8-Table5-1.png)